International reference: 3 US FDA recalls for this ingredient

Labeling -label error on declared strength: unopened, sealed bottle of Terazosin Hydrochloride (HCl) 10mg Capsules contained Terazosin HCl 5 mg Capsules (terazosin)

Presence of Foreign Tablets/Capsules: Recall is being conducted due to a foreign capsule found in one bottle. (terazosin)

Labeling: Label Mixup: TERAZOSIN HCL, Capsule, 5 mg may have potentially been mislabeled as the following drug: DOXAZOSIN MESYLATE, Tablet, 1 mg, NDC 00093812001, Pedigree: W003912, EXP: 6/28/2014. (terazosin)

US-market enforcement records (OpenFDA), shown for reference - not specific to this product in South Africa.

Canceled South Africa · SAHPRA

APEX-TERAZOSIN 2 mg

None

A39/7.1/0420

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
A39/7.1/0420
Registration date
2012/07/27
Expiry date
-
Status
Canceled
Active ingredient
None
Dosage form
-
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
Camox Pharmaceuticals (Pty) Ltd
Country of origin
-

Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:15:30 · updated 2026-09-16 04:00:21

Disclaimer: This information is sourced from South African Health Products Regulatory Authority (South Africa). Always consult a qualified healthcare professional before using any medication.